Victoria L Creamer Charles River Laboratories International, Inc. (CRL) insider trading activity

Victoria L Creamer is EVP & Chief People Officer of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Currently has a direct ownership of 14,829 shares of CRL, which is worth approximately $2.77 Million. The most recent transaction as insider was on May 31, 2024, when has been sold 1,967 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.8K

0% 3M change

10.16% 12M change

Total Value Held $2.77 Million

Victoria L Creamer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 31 2024	BUY Grant, award, or other acquisition	-	1,967 Added 11.71%	14,829 Common Stock
May 29 2024	SELL Payment of exercise price or tax liability	$40,756 $214.51 p/Share	190 Reduced 1.45%	12,947 Common Stock
May 28 2024	SELL Payment of exercise price or tax liability	$16,725 $217.21 p/Share	77 Reduced 0.58%	13,137 Common Stock
May 27 2024	SELL Payment of exercise price or tax liability	$26,499 $217.21 p/Share	122 Reduced 0.91%	13,214 Common Stock
May 26 2024	SELL Payment of exercise price or tax liability	$39,097 $217.21 p/Share	180 Reduced 1.33%	13,336 Common Stock
Feb 29 2024	SELL Open market or private sale	$1,268,500 $253.7 p/Share	5,000 Reduced 26.95%	13,550 Common Stock
Jan 29 2024	SELL Payment of exercise price or tax liability	$209,926 $220.28 p/Share	953 Reduced 4.89%	18,550 Common Stock
Jan 29 2024	BUY Grant, award, or other acquisition	-	2,997 Added 13.32%	19,503 Common Stock
Dec 14 2023	SELL Open market or private sale	$1,243,350 $225.0 p/Share	5,526 Reduced 25.08%	16,506 Common Stock
Dec 14 2023	BUY Exercise of conversion of derivative security	$742,694 $134.4 p/Share	5,526 Added 20.05%	22,032 Common Stock
May 29 2023	SELL Payment of exercise price or tax liability	$36,882 $194.12 p/Share	190 Reduced 1.14%	16,506 Common Stock
May 28 2023	SELL Payment of exercise price or tax liability	$22,323 $194.12 p/Share	115 Reduced 0.68%	16,696 Common Stock
May 27 2023	SELL Payment of exercise price or tax liability	$33,000 $194.12 p/Share	170 Reduced 1.0%	16,811 Common Stock
May 26 2023	BUY Grant, award, or other acquisition	-	2,009 Added 10.58%	16,981 Common Stock
Feb 22 2023	SELL Payment of exercise price or tax liability	$44,091 $243.6 p/Share	181 Reduced 1.19%	14,972 Common Stock
Feb 01 2023	SELL Payment of exercise price or tax liability	$85,136 $248.21 p/Share	343 Reduced 2.21%	15,153 Common Stock
Jan 31 2023	SELL Payment of exercise price or tax liability	$657,628 $244.29 p/Share	2,692 Reduced 14.8%	15,496 Common Stock
Jan 27 2023	BUY Grant, award, or other acquisition	-	7,229 Added 28.44%	18,188 Common Stock
May 29 2022	SELL Payment of exercise price or tax liability	$46,438 $244.41 p/Share	190 Reduced 1.7%	10,959 Common Stock
May 28 2022	SELL Payment of exercise price or tax liability	$27,863 $244.41 p/Share	114 Reduced 1.01%	11,149 Common Stock
May 27 2022	BUY Grant, award, or other acquisition	-	1,493 Added 11.7%	11,263 Common Stock
Feb 22 2022	SELL Payment of exercise price or tax liability	$52,850 $293.61 p/Share	180 Reduced 1.81%	9,770 Common Stock
Feb 01 2022	SELL Payment of exercise price or tax liability	$113,108 $329.76 p/Share	343 Reduced 3.33%	9,950 Common Stock
Jan 28 2022	SELL Payment of exercise price or tax liability	$747,815 $312.24 p/Share	2,395 Reduced 18.88%	10,293 Common Stock
Jan 28 2022	BUY Grant, award, or other acquisition	-	6,302 Added 33.19%	12,688 Common Stock

VLC

Victoria L Creamer

EVP & Chief People Officer

Wilmington, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRL shares.

Notify only if

Value

Insider Trading

Get notified when an Charles River Laboratories International, Inc. insider buys or sells CRL shares.

Notify only if

Operation

Value

Type

News

Receive news related to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Track Activities on CRL

Account